Indonesia Digital Health Market Analysis Report [2022-30] I Insights10

Indonesia Digital Health Market Analysis

$ 3999

The Indonesia Digital Health market is projected to grow from $xxBn in 2022 to $xxBn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market will be driven by the growing population with increasing internet usage and with supportive government initiatives. The market is segmented by solution, by deployment & by end-use. Some of the major players include Halodoc, GrabHealth & K24Klik.

ID: IN10IDDH005 CATEGORY: Digital Health GEOGRAPHY: Indonesia AUTHOR: Vidhi Upadhyay

Buy Now

Indonesia Digital Health Market Executive Summary

The Indonesia Digital Health market is projected to grow from $xxBn in 2022 to $xxBn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Health expenditure per capita in Indonesia observed growth from $111.66 in 2018 to $120.12 in 2019 as recorded by World Health Organization Global Health Expenditure database. Healthcare spending (%GDP) has been comparatively low in comparison to other nations in the area. The government has raised its healthcare spending in recent years, yet there is still a considerable disparity in access to healthcare and the standard of care in rural and low-income areas.

Jakarta is Indonesia's digital health capital owing to its more established digital ecosystem, which includes access to health practitioners, stronger health infrastructure, and more investment possibilities. Demand for digital health is expected to rise in Indonesia with the increasing population. Telemedicine, electronic health records, and health applications are some of the primary areas of growth in Indonesia's digital health business. Digital diabetes is one of the fast-growing sectors in Indonesia, however, the industry is still in its early phase and there are certain problems that need to be solved.

indonesia digital health market analysis

Market Dynamics

Market Growth Drivers

With a population of over 275Mn and 170Mn internet users and growing, healthcare technology innovations, an increasing number of people suffering from chronic diseases, and growing awareness towards digital health, the market is expected to grow. Its geography is spread over a number of islands which makes digital alternatives more accessible to the vast population as compared to physical medical infrastructure & services.

With the support from local government bodies the patient, behavior is also evolving to fill in the gap in access to healthcare services in remote areas. Jakarta is already in the front view when it comes to the adoption of digital health however, other cities such as Surabaya & Bandung have also begun to invest more via grants and incubator programs into digital health start-ups.

Market Restraints

Indonesia has a relatively lower healthcare spending compare to other countries in the area. Other factors such as a limited workforce, limited infrastructure and cyber security, low government funding, and limitation to reimbursement for digital health are the main restraints to the growth of the digital health market in Indonesia.

Competitive Landscape

Key Players

Halodoc (IDN): They provide a platform to connect patients with licensed doctors, insurance, labs, and pharmacies in one simple mobile application
GrabHealth (IDN): In partnership with Chinese platform “Ping An Good Doctor”, provides online health consultation to the patients.
K24Klik (IDN): An e – pharmacy application to allow people to buy drugs online.
Medigo (IDN): Healthtech company that connects healthcare facilities with patients, doctors, insurance, and government under one platform. They seeded funding from Venturra Discovery in April 2019.
Alodokter (IDN): A digital health platform that provides an end-to-end digital solution to patients including telemedicine, doctors, and others.

Healthcare Policies and Regulatory Landscape

The Ministry of Health (MOH) is responsible for the regulation of digital health in Indonesia. In 2020, MOH issued a Regulation on Telemedicine Services to provide free telemedicine services for COVID - 19 patients outside Jakarta. Also, Badan Pengawas Obat dan Makanan (BPOM), the National Agency of Drug and Food Control allowed the pharma industry, wholesalers, and pharmacies to distribute medicine through an electronic system.

As part of the COVID-19 management plans, Indonesia created two national health systems in 2020 and 2021. PeduliLindungi and Vaccination Dashboard have been widely used for public health management, with a significant volume of data interchange taking place on the platform.

Reimbursement Scenario

Telemedicine services and electronic health records are covered under the government's national healthcare insurance scheme, known as JKN. As of December 2021, nearly 223.4 million Indonesians were covered by the National Health Insurance (JKN) However, compensation for these treatments remains restricted and varies according to the type of service delivered. In Indonesia, some private health insurance companies began to offer digital healthcare services, although coverage is restricted and not all services are covered.

The Ministry of Health partnered with the United Nations Development Programme (UNDP) with funding from the Government of Japan and came up with a blueprint, entitled “Blueprint of Health Digital Transformation Strategy 2024” aiming to create a base for improvised digital health infrastructure in Indonesia. It is expected to fasten the national motive to provide affordable, equitable, and quality care.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Digital Health Market Segmentation

The Digital Health Market is segmented as mentioned below:

By Solution (Revenue, USD Billion):

Software
Services

By Deployment (Revenue, USD Billion):

Cloud-based
On-premises

By End-use (Revenue, USD Billion):

Diagnostic Centres
Healthcare Payers
Healthcare Research Centres
Hospitals & Clinics
Nursing Care Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.